Evidence map›Paper›PMID 29607973›Full record

ArticleInternal medicine (Tokyo, Japan)2018

Malignant Pleural Mesothelioma with Bone Marrow Metastases.

Hiroaki Ihara, Norihiro Harada, Naoko Shimada, Koichiro Kanamori, Takuo Hayashi, Toshimasa Uekusa, Kazuhisa Takahashi

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Hiroaki IharaDepartment of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Japan.
Norihiro HaradaDepartment of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Japan.
Naoko ShimadaDepartment of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Japan.
Koichiro KanamoriDepartment of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Japan.
Takuo HayashiDepartment of Human Pathology, Juntendo University Faculty of Medicine and Graduate School of Medicine, Japan.
Toshimasa UekusaDepartment of Pathology, Labour Health and Welfare Organization Kanto Rosai Hospital, Japan.
Kazuhisa TakahashiDepartment of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Japan.
Juntendo University · JPJapan Organization of Occupational Health and Safety · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 64-year-old man with the bone marrow metastasis due to malignant pleural mesothelioma (MPM) was diagnosed with anemia, leukoerythroblastosis, thrombocytopenia, and lower back pain. A bone marrow biopsy demonstrated infiltrative malignant mesothelioma lesions in the bone marrow. The patient died within 15 days of the detection of the bone marrow involvement. Physicians should consider performing a bone marrow biopsy to diagnose bone marrow metastasis and treat patients with palliative chemotherapy at an earlier phase of the disease. To our knowledge, this is the first report of an MPM patient having bone marrow metastasis with anemia, leukoerythroblastosis, and thrombocytopenia.

Indexed as

BiopsyBone NeoplasmsHumansLow Back PainMaleMesotheliomaMiddle AgedPleural Neoplasmsanemiabone marrow metastasisleukoerythroblastosismalignant pleural mesotheliomathrombocytopenia

Identifiers

PMID29607973
PMCPMC6172530
OpenAlexW2794828384

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.